Other languages Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-21 EDT			5-day change	1st Jan Change
13.04 ^USD	-1.66%		+19.30%	+43.30%

05-13	Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-17	North American Morning Briefing : Stock Futures -2-	DJ

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13
Avalo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29
Sector Update: Health Care Stocks Rise Late Afternoon	03-28
Top Midday Gainers	03-28
Wall Street Set to Open Flat in Thursday Trading; Q4 US GDP Revised Up, Weekly Jobless Claims Fall	03-28
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	03-28
US Futures Little Changed Pre-Bell Thursday Ahead of Raft of Economic Data	03-28
Top Premarket Gainers	03-28
Avalo Therapeutics, Inc. acquired AlmataBio, Inc. for $42.5 million.	03-27
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million	03-27
Avalo Therapeutics, Inc. Announces Board Appointments	03-27
Avalo Therapeutics Plans 1-for-240 Reverse Stock Split	12-27
Avalo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Top Midday Gainers	23-09-12
Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Top Midday Decliners	23-06-26
Avalo Says Trial of AVTX-002 to Treat Non-Eosinophilic Asthma Did Not Meet Primary Endpoint; Shares Slump	23-06-26
Avalo Announces Topline Data from Phase 2 Peak Trial for Avtx-002 (Quisovalimab) in Patients with Non-Eosinophilic Asthma	23-06-26
Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04
Avalo Therapeutics Files $375 Million Mixed Shelf	23-04-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Other languages

Filters